← Back to Reviews
📱 Wearable

Sensate 2 — Can Infrasonic Vibration on the Chest Actually Calm the Nervous System?

Sensate delivers low-frequency vibrations to the sternum paired with soundscapes. The claims are about vagal toning and stress reduction. We looked at the evidence behind the buzz.

What Sensate Claims

Sensate is a pebble-shaped device you place on your chest (sternum) while listening to guided audio tracks. It delivers infrasonic vibrations — frequencies below 20 Hz that you feel rather than hear — while the app plays paired soundscapes designed to guide breathing and relaxation.

The company claims the device activates the vagus nerve through chest vibration, reducing stress, improving HRV, and promoting "nervous system resilience." They position it as a technology-assisted shortcut to the benefits of meditation without requiring meditation skill.

The Mechanism Question

The theoretical basis is reasonable: the vagus nerve passes through the thoracic cavity near the sternum. Mechanical vibration can stimulate nerve fibers. Infrasonic frequencies have documented effects on smooth muscle and tissue resonance.

But there's a gap between "the vagus nerve is near the chest" and "a small vibrating pebble on the chest meaningfully stimulates the vagus nerve."

The vagus nerve runs deep — behind the sternum, adjacent to the heart and lungs. Surface-level vibration from a consumer device would need to penetrate several centimeters of bone, muscle, and connective tissue to reach vagal fibers directly. This is physically possible with infrasonic frequencies (which have longer wavelengths and greater tissue penetration than audible sound), but the intensity from a small battery-powered device is unclear.

What the Evidence Shows

Sensate has published two studies:

A 2023 pre-post study (n=126) measured HRV, perceived stress, and sleep quality before and after 30 days of daily Sensate use. Results showed significant improvements in all three measures. However, there was no control group, no blinding, and no way to separate the device effect from the daily guided relaxation practice it's paired with.

A 2024 feasibility RCT (n=56) compared Sensate to a sham device (vibration-off, audio-only). Results showed moderate HRV improvements in the active group compared to sham. This is more convincing, but the sample was small and the study was funded by the company.

No independent replication exists.

The Confound Problem

Here's the issue: every Sensate session involves lying still, breathing slowly, and listening to calming audio for 10-30 minutes. These activities alone — without any device — produce significant parasympathetic shifts.

The question isn't "does using Sensate make you calmer?" (it almost certainly does). The question is "does the vibration add anything beyond what lying down with breathing guidance already provides?"

The sham-controlled study suggests yes — but with small effect sizes that make the answer more "probably a little" than "definitely a lot."

Who It's For

Sensate makes sense for people who:

  • Struggle with traditional meditation and need a physical anchor
  • Want a structured daily calming practice with minimal effort
  • Are interested in vagal toning but don't want cold exposure or breathwork
  • Enjoy the sensory experience of vibration + sound

At $249, the price is modest compared to Apollo Neuro ($349) and other nervous system wearables. The app content is well-designed and the experience is genuinely pleasant.

The Bottom Line

Sensate is a well-designed relaxation tool with plausible but not fully validated vagal stimulation claims. The evidence is early-stage and founder-led. The biggest unanswered question is how much the vibration adds beyond the guided relaxation practice itself.

NORM scored it 48/100 — OVEREXTENDED. The claims outpace the evidence, but the direction is right and the product isn't making dangerous promises. It's a yellow-zone "promising but unproven" story.

A pleasant device that probably helps you relax. Whether it's the vibration or the 10 minutes of stillness doing the work — that's still an open question.